Comparative Expression of ER,PR and HER2/Neu in Initial and Recurrent Breast Cancer.

Enrolling by invitationOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

October 31, 2025

Study Completion Date

December 31, 2025

Conditions
Breast Cancer
Trial Locations (1)

Unknown

Faculty of medicine, Sohag

All Listed Sponsors
lead

Sohag University

OTHER